Business
CSL (ASX:CSL) share price on watch after hints of ‘far more robust’ vaccine – The Motley Fool Australia
Australian global biotech giant, CSL Limited didn’t win the sprint for a coronavirus vaccine. But it may lead the marathon.
The CSL Limited(ASX: CSL) share price is edging higher today, up 0.2% in afternoon trading.
That’s broadly in line with the wider S&P/ASX 200 Index (ASX: XJO), up 0.4% at time of writing.
With a history of generally delivering fairly steady share price growth, 2020 has been unusually volatile for CSL shareholders. While there are various reasons for this, traders jumping in and out of shares based on the latest COVID-19 vaccine news have certainly helped stir this year’s share price volatility.
…
-
Noosa News21 hours agoForensic teams, dogs descend on scene of alleged murder
-
General21 hours agoDrone pilot course in doubt as Queensland reviews school-based training
-
Business18 hours ago3 excellent ASX ETFs for Aussies over 60
-
Noosa News16 hours agoFamilies of house fire victims speak out, ‘overwhelmed with grief’